Esta Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Esta Indonesia Tbk. trades at Rp750 (market cap 2.98T, 26.4M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Esta Indonesia Tbk. is far larger — about 28.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| NEST | SCPI | |
|---|---|---|
Market Cap | 2.98T | 104.4B |
Volume | 26.4M | — |
Lot | 263.98K | — |
Turnover | 19.57B | — |
Average Price | 741.29 | — |
Value | 19.57B | — |
Indicative Equilibrium Price | 750 | — |
Indicative Equilibrium Volume | 1.91K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Esta Indonesia (the Company) was established by Notarial Deed No. 2 dated March 31, 2000 of Angelique Tedjajuwana, S.H., notary in Semarang. The Company started its commercial operations in 2000.
Read more on NEST →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →